Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica C Hassel

Showing results (121-130 of 272) with videos related to

Pageof 28
Sort By:
Journal of Clinical Microbiology|February 8, 2013
Varicella-like cutaneous toxoplasmosis in a patient with aplastic anemiaStefan Zimmermann, Eva Hadaschik, Alexander Dalpke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 18, 2019
Cerebral metastases of a dermatofibrosarcoma protuberansMareen Zielonka, Daniel Debatin, Arno Rütten, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2023
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafuspJessica C Hassel, Carola Berking, Andrea Forschner, et al.
Melanoma Research|March 4, 2017
Reinduction of PD1-inhibitor therapy: first experience in eight patients with metastatic melanomaHanna Blasig, Carolin Bender, Jessica C Hassel, et al.
Scientific Reports|July 7, 2019
Macroangiopathy is a positive predictive factor for response to immunotherapyKaterina Deike-Hofmann, Lukas Gutzweiler, Julia Reuter, et al.
Cancers|October 21, 2020
Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma PatientsMartin Salzmann, Karolina Benesova, Kristina Buder-Bakhaya, et al.
European Journal of Cancer (Oxford, England : 1990)|September 4, 2020
Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter studyMartin Salzmann, Ulrike Leiter, Carmen Loquai, et al.
Life (Basel, Switzerland)|April 3, 2021
Expression of Potential Targets for Cell-Based Therapies on Melanoma CellsSophia B Strobel, Devayani Machiraju, Ingrid Hülsmeyer, et al.
Bone Marrow Transplantation|January 20, 2026
Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphomaIsabelle Krämer, Laila König, Arne Brecht, et al.
Oncoimmunology|June 9, 2021
Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patientsDevayani Machiraju, Melanie Wiecken, Nina Lang, et al.
Pageof 28

Showing results (121-130 of 272) with videos related to

Sort By:
Pageof 28
Journal of Clinical Microbiology|February 8, 2013
Varicella-like cutaneous toxoplasmosis in a patient with aplastic anemiaStefan Zimmermann, Eva Hadaschik, Alexander Dalpke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 18, 2019
Cerebral metastases of a dermatofibrosarcoma protuberansMareen Zielonka, Daniel Debatin, Arno Rütten, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2023
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafuspJessica C Hassel, Carola Berking, Andrea Forschner, et al.
Melanoma Research|March 4, 2017
Reinduction of PD1-inhibitor therapy: first experience in eight patients with metastatic melanomaHanna Blasig, Carolin Bender, Jessica C Hassel, et al.
Scientific Reports|July 7, 2019
Macroangiopathy is a positive predictive factor for response to immunotherapyKaterina Deike-Hofmann, Lukas Gutzweiler, Julia Reuter, et al.
Cancers|October 21, 2020
Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma PatientsMartin Salzmann, Karolina Benesova, Kristina Buder-Bakhaya, et al.
European Journal of Cancer (Oxford, England : 1990)|September 4, 2020
Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter studyMartin Salzmann, Ulrike Leiter, Carmen Loquai, et al.
Life (Basel, Switzerland)|April 3, 2021
Expression of Potential Targets for Cell-Based Therapies on Melanoma CellsSophia B Strobel, Devayani Machiraju, Ingrid Hülsmeyer, et al.
Bone Marrow Transplantation|January 20, 2026
Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphomaIsabelle Krämer, Laila König, Arne Brecht, et al.
Oncoimmunology|June 9, 2021
Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patientsDevayani Machiraju, Melanie Wiecken, Nina Lang, et al.
Pageof 28